300015.SZ
Aier Eye Hospital Group Co., Ltd. [300015.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300015.SZ Stock Summary
Top 10 Correlated ETFs
300015.SZ
Top 10 Correlated Stocks
300015.SZ
In the News
300015.SZ Financial details
Company Rating
Strong Buy
Market Cap
113.6B
Income
3.3B
Revenue
19.11B
Book val./share
2.03
Cash/share
0.82
Dividend
0.1
Dividend %
0.67%
Employees
32.33K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
31.88
Forward P/E
-
PEG
8.53
P/S
7.29
P/B
5.62
P/C
14.8
P/FCF
43.54
Quick Ratio
1.56
Current Ratio
1.7
Debt / Equity
0.25
LT Debt / Equity
0.18
-
-
EPS (TTM)
0.36
EPS next Y
-
EPS next Q
-
EPS this Y
3.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.47%
Revenue last 5Y
15%
Revenue Q/Q
10.78%
EPS Q/Q
60%
-
-
-
-
SMA20
-14.29%
SMA50
-14.29%
SMA100
-33.33%
Inst Own
0%
Inst Trans
0%
ROA
11%
ROE
19%
ROC
0.19%
Gross Margin
51%
Oper. Margin
24%
Profit Margin
17%
Payout
23%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
12.2-24.153015
52W High
-49.42%
52W Low
+1.17%
RSI
35
Rel Volume
1.08
Avg Volume
73.91M
Volume
79.52M
Perf Week
-3.88%
Perf Month
-14.39%
Perf Quarter
-26.87%
Perf Half Y
-31.14%
-
-
-
-
Beta
0.465
-
-
Volatility
0.13%, 0.65%
Prev Close
-2.25%
Price
12.14
Change
-2.72%
300015.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.18 | 1.14 | 1.34 | 1.66 | 1.75 | |
| Net income per share | 0.15 | 0.16 | 0.19 | 0.26 | 0.27 | |
| Operating cash flow per share | 0.21 | 0.24 | 0.37 | 0.45 | 0.49 | |
| Free cash flow per share | 0.09 | 0.15 | 0.27 | 0.29 | 0.34 | |
| Cash per share | 0.12 | 0.24 | 0.38 | 0.52 | 0.75 | |
| Book value per share | 0.84 | 0.75 | 1.1 | 1.25 | 1.81 | |
| Tangible book value per share | 0.5 | 0.44 | 0.7 | 0.79 | 1.23 | |
| Share holders equity per share | 0.84 | 0.75 | 1.1 | 1.25 | 1.81 | |
| Interest debt per share | 0.26 | 0.3 | 0.24 | 0.62 | 0.51 | |
| Market cap | 80.3B | 122B | 305.12B | 226.65B | 220.57B | |
| Enterprise value | 80.73B | 122.68B | 304.14B | 227.73B | 219.12B | |
| P/E ratio | 79.59 | 88.47 | 177 | 97.55 | 87.38 | |
| Price to sales ratio | 10.03 | 12.21 | 25.61 | 15.11 | 13.69 | |
| POCF ratio | 57.36 | 58.7 | 91.25 | 55.5 | 49.12 | |
| PFCF ratio | 136.29 | 91.53 | 124.54 | 87.51 | 71.1 | |
| P/B Ratio | 14.11 | 18.5 | 30.96 | 20.04 | 13.23 | |
| PTB ratio | 14.11 | 18.5 | 30.96 | 20.04 | 13.23 | |
| EV to sales | 10.08 | 12.28 | 25.53 | 15.18 | 13.6 | |
| Enterprise value over EBITDA | 42.88 | 45.92 | 82.64 | 44.95 | 42.1 | |
| EV to operating cash flow | 57.67 | 59.03 | 90.96 | 55.76 | 48.79 | |
| EV to free cash flow | 137.02 | 92.05 | 124.14 | 87.92 | 70.63 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.3 | 0.38 | 0.21 | 0.48 | 0.27 | |
| Debt to assets | 0.18 | 0.21 | 0.13 | 0.25 | 0.17 | |
| Net debt to EBITDA | 0.23 | 0.26 | -0.27 | 0.21 | -0.28 | |
| Current ratio | 1.58 | 1.4 | 1.69 | 1.15 | 1.8 | |
| Interest coverage | 28.38 | 29.36 | 35.48 | 21.22 | 19.9 | |
| Income quality | 1.31 | 1.45 | 1.78 | 1.65 | 1.67 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.52 | 0.37 | 0.31 | 0.29 | 0.27 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.27 | 0.27 | 0.28 | 0.23 | 0.24 | |
| Capex to operating cash flow | -0.58 | -0.36 | -0.27 | -0.37 | -0.31 | |
| Capex to revenue | -0.1 | -0.07 | -0.08 | -0.1 | -0.09 | |
| Capex to depreciation | -3.08 | -2.12 | -2.15 | -1.57 | -1.19 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
| Graham number | 1.68 | 1.63 | 2.19 | 2.69 | 3.33 | |
| ROIC | 0.16 | 0.17 | 0.18 | 0.14 | 0.12 | |
| Return on tangible assets | 0.14 | 0.16 | 0.16 | 0.14 | 0.12 | |
| Graham Net | -0.27 | -0.16 | 0 | -0.36 | -0.03 | |
| Working capital | 1.18B | 1.15B | 2.31B | 939.34M | 4.29B | |
| Tangible asset value | 3.4B | 3.83B | 6.23B | 7.16B | 11.34B | |
| Net current asset value | -429.86M | -844.94M | 757.08M | -2.41B | 693.84M | |
| Invested capital | 0.3 | 0.38 | 0.21 | 0.48 | 0.27 | |
| Average receivables | 989.28M | 1.31B | 1.61B | 1.8B | 1.88B | |
| Average payables | 826.62M | 1.02B | 1.27B | 1.42B | 1.42B | |
| Average inventory | 316.43M | 366.63M | 434.38M | 532.95M | 651.16M | |
| Days sales outstanding | 52.09 | 53.95 | 53.36 | 45.33 | 42.98 | |
| Days payables outstanding | 81.05 | 78.68 | 90.97 | 69.84 | 67.04 | |
| Days of inventory on hand | 30.87 | 26.97 | 30.94 | 28.92 | 33.43 | |
| Receivables turnover | 7.01 | 6.77 | 6.84 | 8.05 | 8.49 | |
| Payables turnover | 4.5 | 4.64 | 4.01 | 5.23 | 5.44 | |
| Inventory turnover | 11.82 | 13.53 | 11.8 | 12.62 | 10.92 | |
| ROE | 0.18 | 0.21 | 0.17 | 0.21 | 0.15 | |
| Capex per share | -0.12 | -0.08 | -0.1 | -0.17 | -0.15 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.92 | 0.33 | 0.54 | 0.57 | 0.63 | |
| Net income per share | 0.2 | 0.01 | 0.08 | 0.1 | 0.16 | |
| Operating cash flow per share | 0.2 | 0.01 | 0.08 | 0.19 | 0.24 | |
| Free cash flow per share | 0.15 | -0.04 | 0.06 | 0.15 | 0.19 | |
| Cash per share | 1.62 | 0.75 | 0.8 | 0.77 | 0.82 | |
| Book value per share | 3.03 | 1.81 | 1.9 | 1.89 | 2.03 | |
| Tangible book value per share | 2.17 | 1.23 | 1.29 | 1.27 | 1.42 | |
| Share holders equity per share | 3.03 | 1.81 | 1.9 | 1.89 | 2.03 | |
| Interest debt per share | 0.94 | 0.5 | 0.53 | 0.5 | 0.5 | |
| Market cap | 118.22B | 220.57B | 220.57B | 171.32B | 165.96B | |
| Enterprise value | 114.84B | 219.12B | 218.89B | 169.58B | 163.75B | |
| P/E ratio | 27.73 | 475.8 | 70.6 | 45.99 | 28.25 | |
| Price to sales ratio | 23.91 | 72.12 | 43.93 | 32.75 | 28.64 | |
| POCF ratio | 110.93 | 1.9K | 282.4 | 99.84 | 75.26 | |
| PFCF ratio | 148.79 | -544.1 | 410.56 | 127.19 | 96.36 | |
| P/B Ratio | 7.28 | 13.23 | 12.6 | 9.81 | 8.87 | |
| PTB ratio | 7.28 | 13.23 | 12.6 | 9.81 | 8.87 | |
| EV to sales | 23.23 | 71.65 | 43.6 | 32.42 | 28.25 | |
| Enterprise value over EBITDA | 72.8 | 412.38 | 187.61 | 122.82 | 83.34 | |
| EV to operating cash flow | 107.75 | 1.89K | 280.25 | 98.83 | 74.25 | |
| EV to free cash flow | 144.53 | -540.52 | 407.43 | 125.9 | 95.08 | |
| Earnings yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Debt to equity | 0.3 | 0.27 | 0.28 | 0.26 | 0.25 | |
| Debt to assets | 0.18 | 0.17 | 0.17 | 0.16 | 0.15 | |
| Net debt to EBITDA | -2.15 | -2.73 | -1.44 | -1.26 | -1.13 | |
| Current ratio | 1.73 | 1.8 | 1.73 | 1.62 | 1.7 | |
| Interest coverage | 12.09 | 2.71 | 23.78 | 27.5 | 40.6 | |
| Income quality | 1 | 1 | 1 | 1.84 | 1.5 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.61 | 0.03 | 0.01 | 0.78 | 0.01 | |
| Sales general and administrative to revenue | 0.32 | -0.43 | 0.13 | -0.07 | 0.3 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.21 | 0.24 | 0.24 | 0.24 | 0.22 | |
| Capex to operating cash flow | -0.25 | -4.5 | -0.31 | -0.22 | -0.22 | |
| Capex to revenue | -0.05 | -0.17 | -0.05 | -0.07 | -0.08 | |
| Capex to depreciation | -0.72 | -1.39 | -0.58 | -0.87 | 0.73 | |
| Stock based compensation to revenue | -0.02 | 0.07 | 0 | 0.01 | -0.01 | |
| Graham number | 3.68 | 0.71 | 1.9 | 2.07 | 2.69 | |
| ROIC | 0.05 | 0.01 | 0.04 | 0.04 | 0.06 | |
| Return on tangible assets | 0.05 | 0.01 | 0.04 | 0.04 | 0.06 | |
| Graham Net | 0.14 | -0.03 | -0.05 | -0.09 | -0.04 | |
| Working capital | 4.79B | 4.29B | 4.35B | 3.94B | 4.47B | |
| Tangible asset value | 11.63B | 11.34B | 11.9B | 11.73B | 13.09B | |
| Net current asset value | 1.63B | 693.84M | 533.5M | 272.37M | 722.45M | |
| Invested capital | 0.3 | 0.27 | 0.28 | 0.26 | 0.25 | |
| Average receivables | 2.01B | 1.96B | 2.02B | 2.2B | 2.29B | |
| Average payables | 1.63B | 1.53B | 1.68B | 2.11B | 2.29B | |
| Average inventory | 581.42M | 655.04M | 706.74M | 784.95M | 843.8M | |
| Days sales outstanding | 36.65 | 55.83 | 38.47 | 38.95 | 35.89 | |
| Days payables outstanding | 66.08 | 77.4 | 64.66 | 82.15 | 80.03 | |
| Days of inventory on hand | 24.05 | 38.6 | 23.3 | 31.38 | 28.44 | |
| Receivables turnover | 2.46 | 1.61 | 2.34 | 2.31 | 2.51 | |
| Payables turnover | 1.36 | 1.16 | 1.39 | 1.1 | 1.12 | |
| Inventory turnover | 3.74 | 2.33 | 3.86 | 2.87 | 3.16 | |
| ROE | 0.07 | 0.01 | 0.04 | 0.05 | 0.08 | |
| Capex per share | -0.05 | -0.06 | -0.03 | -0.04 | -0.05 |
300015.SZ Frequently Asked Questions
What is Aier Eye Hospital Group Co., Ltd. stock symbol ?
Aier Eye Hospital Group Co., Ltd. is a CN stock and trading under the symbol 300015.SZ
What is Aier Eye Hospital Group Co., Ltd. stock quote today ?
Aier Eye Hospital Group Co., Ltd. stock price is $12.14 today.
Is Aier Eye Hospital Group Co., Ltd. stock public?
Yes, Aier Eye Hospital Group Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 73.91M
- Market Capitalization 113.6B
- Employee 32.33K
- CEO Mr. Bang Chen
- Headquarters Changsha,CN
- IPO Date 2009-10-30
-
Website
https://www.aierchina.com 
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
